This product is suitable for qualitative detection of HLA-B*5801 gene polymorphism in human whole blood samples in vitro.
Successfully obtained in the EU CE access certification.
Main clinical applications:
1. Allopurinol safe and rational drug use guidance
The HLA-B*5801 test can guide clinicians to rationalize the use of medication: for patients with a positive test, it is recommended that allopurinol be prohibited to avoid causing serious damage to patients. Negative patients can use allopurinol according to the doctor's instructions, and pay attention to the drug reaction.
Applicable Instruments:
HONGSHI SLAN-96, ABI 7500, and other four-channel fluorescence PCR instruments.
Main Product Performance:
1.High sensitivity
Unique nucleic acid invasion signal amplification technology, the lowest detection limit of 0.2 ng/µL;
2.Wide detection range
0.2 ng/µL - 100 ng/µL;
3.Lyophilized reagent
Good stability, no need for cold chain transportation, cost savings;
4.Convenient operation
The whole premixed dispensing, ready to use, no need to dispense liquid.